Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer

Targeting histone demethylases JMJD3 and UTX: selenium as a potential therapeutic agent for cervical cancer

Abstract Background The intriguing connection between selenium and cancer resembles a captivating puzzle that keeps researchers engaged and curious. While selenium has shown promise in reducing cancer risks through supplementation, its interaction with epigenetics in cervical cancer remains a fascin...

Full description

Bibliographic Details
Main Authors: Dezhi Chen, Bo Cai, Yingying Zhu, Yimin Ma, Xiaoting Yu, Jieqi Xiong, Jiaying Shen, Weiwei Tie, Yisheng Zhang, Fei Guo
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Clinical Epigenetics
Subjects:
Selenium
Cervical cancer
JMJD3
UTX
H3K27 methylation
Online Access:https://doi.org/10.1186/s13148-024-01665-3

Internet

https://doi.org/10.1186/s13148-024-01665-3

Similar Items